ResearchMoz: High Level Of Maturity In Global H1N1 Vaccines Market During The Forecast Period 2016 - 2020

Researchmoz added Most up-to-date research on "ResearchMoz: High Level Of Maturity In Global H1N1 Vaccines Market During The Forecast Period 2016 - 2020" to its huge collection of research reports.

The high level of maturity in the H1N1 vaccines market has renewed the push to develop quadrivalent vaccines that address areas of the market with unmet medical needs. Vaccines that prevent H1N1 have been a long-standing void in the treatment algorithm. Therefore, the introduction advanced vaccines in the next decade will likely alter the global H1N1 vaccines market landscape. Sanofi, AstraZeneca, and VaxInnate have also invested in quadrivalent vaccines, such as Sanofi's VaxiGrip, VaxInnate's VAX2012Q, and AstraZeneca's MEDI-550 vaccine, which will impact the US and Europe markets during the forecast period. Other areas of opportunity for novel entrants include vaccines with improved immune response and immunogenic infant vaccines.

Technavios analysts forecast the global H1N1 vaccines market to grow at a CAGR of 4.17% during the period 2016-2020.

Covered in this report
The report covers the present scenario and the growth prospects of the global H1N1 vaccines market for 2016-2020. To calculate the market size, the report considers revenue generated from the sales of vaccines used to prevent H1N1 infection. The report also considers the revenues to be generated from the sales of vaccines that are expected to be launched into the market during the forecast period.

The market is divided into the following segments based on geography:
Americas
APAC
EMEA

Technavio's report, Global H1N1 Vaccines Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
Sanofi
GSK
Astra Zeneca
CSL

To Get Sample Copy of Report visit @ http://www.researchmoz.us/enquiry.php?type=S&repid=741705

Other prominent vendors
Abbott
Baxter International
CEL-SCI
Cipla
Crucell
Denka Seiken
Green Cross
Hualan Biological Engineering
iBio
Imunoloski Zavod
Inovio Biomedical
Lupin
Medicago USA
Merck
Mitsubishi Tanabe Pharma
Omnivest
Panacea
Pfizer
Protein Sciences
Serum Institute of India
Sinovac Biotech
Solvay
Zhejiang Tianyuan Bio-pharmaceuticals
Zydus Cadila

Market driver
Global action plan for influenza vaccines
For a full, detailed list, view our report

Market challenge
Vaccine storage and handling issues
For a full, detailed list, view our report

Market trend
Improved understanding of immunology
For a full, detailed list, view our report

Key questions answered in this report
What will the market size be in 2020 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?

Make an Enquiry of this report @ http://www.researchmoz.us/enquiry.php?type=E&repid=741705

About ResearchMoz

ResearchMoz is the one stop online destination to find and buy market research reports & Industry Analysis. We fulfill all your research needs spanning across industry verticals with our huge collection of market research reports. We provide our services to all sizes of organizations and across all industry verticals and markets. Our Research Coordinators have in-depth knowledge of reports as well as publishers and will assist you in making an informed decision by giving you unbiased and deep insights on which reports will satisfy your needs at the best price.

Mr. Nachiket
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States
Email: sales@researchmoz.us
Website @ http://www.researchmoz.us/
Tel: 866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-621-2074
Follow us on LinkedIn @ http://bit.ly/1TBmnVG

This release was published on openPR.